<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The main role of insulin in the heart under physiological conditions is obviously the regulation of substrate utilization </plain></SENT>
<SENT sid="1" pm="."><plain>Indeed, insulin promotes <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake and its utilization via glycolysis </plain></SENT>
<SENT sid="2" pm="."><plain>Insulin, promoting <z:chebi fb="105" ids="17234">glucose</z:chebi> as the main cardiac energy substrate, reduces myocardial <z:chebi fb="0" ids="15379">O(2)</z:chebi> consumption and increases cardiac efficiency </plain></SENT>
<SENT sid="3" pm="."><plain>Moreover, insulin seems to augment cardiomyocyte contraction, while it affects favorably myocardial relaxation, increases ribosomal biogenesis and protein synthesis, stimulates vascular endothelial growth factor (VEGF) and thereby <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, suppresses <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, promotes cell survival and finally ameliorates both myocardial microcirculation and coronary artery resistance, leading to increased blood perfusion of myocardium </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, insulin acts directly on heart muscle, and this action is mediated principally through PKB/Akt signal pathway </plain></SENT>
<SENT sid="5" pm="."><plain>Under pathological conditions, such as type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischaemia</z:e>, and <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp>, insulin signal transduction pathways and action are clearly modified </plain></SENT>
<SENT sid="6" pm="."><plain>In this review we summarize the evidence that the heart is an important target of insulin action and that elimination of these actions is important in <z:mp ids='MP_0002054'>disease states</z:mp> </plain></SENT>
</text></document>